(Q53241698)

English

A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.

scientific article published on 15 February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

World Health Organization

1 reference

based on heuristic

inferred from title

Peter Vandenberghe

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

0 references

author name string

Verburgh E

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Achten R

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Louw VJ

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Brusselmans C

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Delforge M

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Boogaerts M

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Hagemeijer A

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Verhoef G

9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

publication date

15 February 2007

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

21

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

668-677

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404564

0 references

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

21 January 2018

Language and the clonal myeloid diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphologic classification of the myelodysplastic syndromes (MDS): Combined utilization of bone marrow aspirates and trephine biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterogeneity of acquired idiopathic sideroblastic anaemia (AISA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of the International Prognostic Scoring System for myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

The WHO classification of MDS does make a difference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Two types of acquired idiopathic sideroblastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic syndromes: a scoring system with prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404564

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404564

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17301818

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53241698&oldid=1466104107"